Together. For A Cure. Now. Alzheimer's Research UK launched a powerful new film to highlight the importance of dementia ...
Walk For A Cure is back for 2025 and this year, Alzheimer’s Research UK will be hosting walks at eight exciting locations across the UK. In 2024, we were proud to have 3,386 participants join our ...
FREE entry for Maverick 50km Ultra Marathons, when you fundraise £250. If you already have a place in this event but would like to support Alzheimer’s Research UK, we’d love to have you on the team!
If you already have a place in this event but would like to support Alzheimer’s Research UK, we’d love to have you on the team! There’s no minimum sponsorship target and we can provide help and ...
If you already have a place in this event but would like to support Alzheimer’s Research UK, we’d love to have you on the team! There’s no minimum sponsorship target and we can provide help and ...
If you already have a place in this event but would like to support Alzheimer’s Research UK, we’d love to have you on the team! There’s no minimum sponsorship target and we can provide help and ...
All applications for funds are reviewed by the Organising Committee, with conflicts of interest appropriately managed. New opportunities for 2025 Pump Priming awards, Equipment and Travel Awards will ...
Next-Gen diagnostics & monitoring: biomarkers and innovations in Big Data and AI Co-pathologies and co-morbidities in dementia Translational insights and interdisciplinary innovations Boosting ...
If you already have a place in this event but would like to support Alzheimer’s Research UK, we’d love to have you on the team! There’s no minimum sponsorship target and we can provide help and ...
If you already have a place in this event but would like to support Alzheimer’s Research UK, we’d love to have you on the team! There’s no minimum sponsorship target and we can provide help and ...
Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...